Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act Introduced

US Senator Kay Hagan (D-North Carolina) has proposed legislation that aims to provide faster access to new drugs that address unmet medical needs, significantly advance the standard of care, or target a serious or life-threatening disease or condition.

The bill could also expand FDA’s use of conflict of interest waivers in forming advisory committees, a provision that may prove controversial. The legislation specifies several other process changes and enhancements (but no new funding) for the agency. More information is available on Senator Hagan’s website.

Share This Post